IP Library Granted Patent US 10,828,436
Granted Patent B2
US 10,828,436 · App. 15/480,280 · Granted Nov 10, 2020

Administering the noble gas argon during cardiopulmonary resuscitation

Inventors: Matthias L. Riess (Nashville, TN); Demetris Yannopoulos (Minneapolis, MN); Tom P. Aufderheide (Milwaukee, WI)
Assignees: Vanderbilt University; Medical College of Wisconsin
A61M16/00A61K9/007A61K41/0004A61M16/0003A61M16/12A61H31/00A61H2201/5071A61H2230/205A61H2230/207A61H2230/42A61M16/0078A61M2202/02A61M2202/025A61M2202/0208A61M2202/0258A61M2205/05A61M2230/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,828,436
App. No.
15/480,280
Granted
Nov 10, 2020
Kind
B2
Abstract

Method of treating an individual following a period of ischemia are provided. The methods include administering inhaled agents postconditioning to the individual and optionally simultaneously performing cardiopulmonary resuscitation. The inhaled agents include at least one noble gas.

Claims (32)

1. A method of treating an individual following a period of ischemia, the method comprising:

administering inhaled agent postconditioning, the inhaled agent comprising at least one non-anesthetic noble gas; and

performing cardiopulmonary resuscitation simultaneously with the step of administering inhaled agent postconditioning;

wherein the inhaled agent does not include any volatile anesthetics; and

wherein the inhaled agent includes at least 50% of the at least one non-anesthetic noble gas.

2. The method of claim 1 , wherein the at least one non-anesthetic noble gas is selected from the group consisting of argon, helium, and a combination thereof.

3. The method of claim 1 , wherein the at least one non-anesthetic noble gas is a pure noble gas.

4. The method of claim 1 , wherein the inhaled agent comprises a mixture of the at least one non-anesthetic noble gas and oxygen.

5. The method of claim 4 , wherein the at least one non-anesthetic noble gas is selected from the group consisting of argon, helium, and a combination thereof.

6. The method of claim 4 , wherein the mixture of the at least one non-anesthetic noble gas:oxygen ratio of the mixture is 80:20.

7. The method of claim 4 , wherein the mixture of the at least one non-anesthetic noble gas:oxygen ratio of the mixture is 70:30.

8. The method of claim 4 , wherein the mixture of the at least one non-anesthetic noble gas:oxygen ratio of the mixture is 60:40.

9. The method of claim 4 , wherein the mixture of the at least one non-anesthetic noble gas:oxygen ratio of the mixture is 50:50.

10. The method of claim 1 , wherein the inhaled agent postconditioning is administered within 15 minutes of the period of ischemia.

11. The method of claim 1 , wherein the inhaled agent postconditioning is administered at least 10 minutes after the period of ischemia.

12. The method of claim 1 , wherein the inhaled agent postconditioning is administered at least 15 minutes after the period of ischemia.

13. The method of claim 1 , wherein the method reduces reperfusion injury following the period of ischemia.

14. The method of claim 1 , wherein the non-anesthetic noble gas consists of argon.

15. The method of claim 4 , wherein the non-anesthetic noble gas consists of argon.

16. A method to reduce injury of cells after a period of ischemia the method comprising:

administering non-anesthetic inhaled agent postconditioning; and

performing cardiopulmonary resuscitation simultaneously with the step of administering non-anesthetic inhaled agent postconditioning;

wherein the inhaled agent comprises at least one non-anesthetic noble gas;

wherein the inhaled agent includes at least 50% of the at least one non-anesthetic noble gas; and

wherein the inhaled agent does not include any volatile anesthetics.

17. The method of claim 16 , wherein the cells are myocardial cells.

18. The method of claim 16 , wherein the cells are neuronal cells.

19. A method performing cardiopulmonary resuscitation to an individual comprising:

repeatedly compressing the individual's chest, wherein the chest is compressed during a compression phase followed by a decompression or relaxation phase; and

simultaneously with the compressing step, administering non-anesthetic inhaled agent postconditioning to the individual receiving cardiopulmonary resuscitation;

wherein the inhaled agent comprises at least one non-anesthetic noble gas; and

wherein the inhaled agent includes at least 50% of the at least one non-anesthetic noble gas.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2021
From: VANDERBILT UNIVERSITY
To: VANDERBILT UNIVERSITY; THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 058167/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2020
From: AUFDERHEIDE, TOM P
To: MEDICAL COLLEGE OF WISCONSIN
Reel/Frame 053727/0001 →
CONFIRMATORY LICENSE Recorded Jul 3, 2018
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046259/0926 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAMES AND ATTACH PROPER ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON REEL 043439 FRAME 0308. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 11, 2018
From: RIESS, MATTHIAS L.
To: VANDERBILT UNIVERSITY
Reel/Frame 046306/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2017
From: RIESS, MATTHIAS L; YANNOPOULOS, DEMETRIS; AUFDERHEIDE, TOM P
To: VANDERBILT UNIVERSITY
Reel/Frame 043439/0308 →
Continuity (2)
Provisional Application 62318759 · Apr 5, 2016
Related Publication 20170312460A1 · Nov 2, 2017